Imipenem

What is Imipenem?

Imipenem is a potent, broad-spectrum carbapenem antibiotic, typically co-formulated with cilastatin, an enzyme inhibitor. This combination, known as Imipenem/cilastatin, ensures optimal therapeutic levels by preventing rapid breakdown in the kidneys. It is a cornerstone in the treatment of severe, life-threatening bacterial infections, especially those caused by multi-drug resistant organisms where other antibiotics may have failed. Its wide range of activity against both Gram-positive and Gram-negative bacteria, including anaerobes, makes it crucial in critical care.

Classified under the ATC code J01 (Antibacterial for systemic use), Imipenem is vital in hospital settings. Its broad spectrum makes it valuable for empirical therapy in critically ill patients before specific pathogen susceptibility is known. It is effective against a vast array of bacteria, including Pseudomonas aeruginosa, Acinetobacter species, and ESBL-producing Enterobacteriaceae. Cilastatin inhibits dehydropeptidase-I, an enzyme in renal tubules that metabolizes Imipenem, increasing its urinary concentration and reducing nephrotoxicity risk.

Mechanism of Action

Imipenem exerts its powerful bactericidal effect by interfering with the synthesis of the bacterial cell wall, a vital structure for bacterial survival. It actively kills bacteria rather than just inhibiting growth.

• Imipenem is a beta-lactam antibiotic that binds to and inactivates penicillin-binding proteins (PBPs) on the inner membrane of the bacterial cell wall.
• PBPs are crucial enzymes for peptidoglycan synthesis, cross-linking the strands that form the cell wall's rigid structure.
• By binding to PBPs (particularly PBP-2 and PBP-1a/b), Imipenem inhibits transpeptidation, preventing stable peptidoglycan formation.
• This disruption leads to structural defects, increased permeability, and ultimately, osmotic lysis and bacterial cell death.
• Cilastatin is not antibacterial but inhibits dehydropeptidase. It prevents rapid enzymatic hydrolysis of Imipenem in renal tubules, increasing active Imipenem concentration and prolonging its half-life.

Medical Uses

Primary Uses:

• Complicated intra-abdominal infections (e.g., peritonitis).
• Lower respiratory tract infections (e.g., severe pneumonia, hospital-acquired pneumonia).
• Complicated urinary tract infections (e.g., pyelonephritis).
• Gynecological infections (e.g., endometritis).
• Septicemia (bloodstream infections).
• Bone and joint infections (e.g., osteomyelitis).
• Skin and soft tissue infections (e.g., cellulitis, diabetic foot infections).

Secondary Uses:

• Bacterial endocarditis (multi-drug resistant bacteria).
• Bacterial meningitis (when other agents are ineffective).
• Empirical therapy for febrile neutropenia.
• Infections in immunocompromised patients.

Dosage

Side Effects

Common Side Effects:

• Nausea, vomiting, diarrhea.
• Skin rash (urticaria, pruritus).
• Injection site reactions (pain, erythema).
• Elevated liver enzymes (transaminases).
• Eosinophilia, thrombocytosis.

Rare but Serious Side Effects:

• Seizures and other CNS effects (especially with pre-existing CNS disorders or renal impairment).
• Severe hypersensitivity reactions (anaphylaxis).
• Clostridium difficile-associated diarrhea (CDAD) or pseudomembranous colitis.
• Renal impairment or acute kidney injury.
• Stevens-Johnson syndrome, toxic epidermal necrolysis.
• Neutropenia, leukopenia.

Warnings

Imipenem is contraindicated in patients with known hypersensitivity to Imipenem, cilastatin, or any formulation component. Avoid in individuals with a history of severe allergic reactions to other beta-lactam antibiotics due to cross-reactivity risk. Caution is advised for patients with CNS disorders (e.g., epilepsy) as it can lower the seizure threshold. Dosage adjustments are necessary for renal impairment to prevent accumulation and reduce adverse effects, particularly CNS toxicity.

This article provides general medical information about Imipenem and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making any decisions related to your health or treatment. The information presented here is for educational purposes only and may not cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. Never disregard professional medical advice or delay in seeking it because of something you have read here.